Global Device Approvals Snapshot, 16-22 July 2019: MED-EL Cochlear Implant, Novilase Breast Therapy
Executive Summary
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, the US FDA approved a panel-track PMA supplement for an expanded indication for MED-EL’s cochlear implant, and Novian Health’s Novilase breast cancer treatment earned a CE mark.